7Baggers
 CytoMed Therapeutics Secures Non-Dilutive Investment for  GlobeNewswire Thu, 06 Nov 2025 13:00:00 GMT
 published on: 2025-11-05 01:51:41  newser.com Wed, 05 Nov 2025 07:51:41 GMT

CytoMed Therapeutics Limited
(NASDAQ:GDTC) 

GDTC stock logo

CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company's lead product candidate is CTM-N2D, which consists of expanded gamma delta T cells grafted with natural killer group 2D liga...

Founded: 2018
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends